MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335–5p signaling pathway
Background: The decreased osteogenic differentiation ability of mesenchymal stem cells (MSCs) is one of the important reasons for SOP. Inhibition of Wnt signaling in MSCs is closely related to SOP. Microtubule actin crosslinking factor 1 (MACF1) is an important regulator in Wnt/β-catenin signal tran...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Journal of Orthopaedic Translation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214031X2300013X |
_version_ | 1797837095525416960 |
---|---|
author | Kewen Zhang Wuxia Qiu Hui Li Jun Li Pai Wang Zhihao Chen Xiao Lin Airong Qian |
author_facet | Kewen Zhang Wuxia Qiu Hui Li Jun Li Pai Wang Zhihao Chen Xiao Lin Airong Qian |
author_sort | Kewen Zhang |
collection | DOAJ |
description | Background: The decreased osteogenic differentiation ability of mesenchymal stem cells (MSCs) is one of the important reasons for SOP. Inhibition of Wnt signaling in MSCs is closely related to SOP. Microtubule actin crosslinking factor 1 (MACF1) is an important regulator in Wnt/β-catenin signal transduction. However, whether the specific expression of MACF1 in MSC regulates SOP and its mechanism remains unclear. Methods: We established MSC-specific Prrx1 (Prx1) promoter-driven MACF1 conditional knock-in (MACF-KI) mice, naturally aged male mice, and ovariectomized female mice models. Micro-CT, H&E staining, double calcein labeling, and the three-point bending test were used to explore the effects of MACF1 on bone formation and bone microstructure in the SOP mice model. Bioinformatics analysis, ChIP-PCR, qPCR, and ALP staining were used to explore the effects and mechanisms of MACF1 on MSCs’ osteogenic differentiation. Results: Microarray analysis revealed that the expression of MACF1 and positive regulators of the Wnt pathway (such as TCF4, β-catenin, Dvl) was decreased in human MSCs (hMSCs) isolated from aged osteoporotic than non-osteoporotic patients. The ALP activity and osteogenesis marker genes (Alp, Runx2, and Bglap) expression in mouse MSCs was downregulated during aging. Furthermore, Micro-CT analysis of the femur from 2-month-old MSC-specific Prrx1 (Prx1) promoter-driven MACF1 conditional knock-in (MACF-cKI) mice showed no significant trabecular bone changes compared to wild-type littermate controls, whereas 18- and 21-month-old MACF1 c-KI animals displayed increased bone mineral densities (BMD), improved bone microstructure, and increased maximum compression stress. In addition, the ovariectomy (OVX)-induced osteoporosis model of MACF1 c-KI mice had significantly higher trabecular volume and number, and increased bone formation rate than that in control mice. Mechanistically, ChIP-PCR showed that TCF4 could bind to the promoter region of the host gene miR-335–5p. Moreover, MACF1 could regulate the expression of miR-335–5p by TCF4 during the osteogenic differentiation of MSCs. Conclusion: These data indicate that MACF1 positively regulates MSCs osteogenesis and bone formation through the TCF4/miR-335-5p signaling pathway in SOP, suggesting that targeting MACF1 may be a novel therapeutic approach against SOP. The translational potential of this article: MACF1, an important switch in the Wnt signaling pathway, can alleviate SOP through the TCF4/miR-335-5p signaling pathway in mice model. It might act as a therapeutic target for the treatment of SOP to improve bone function. |
first_indexed | 2024-04-09T15:20:23Z |
format | Article |
id | doaj.art-610da7cd26ff4b958e1c3d0b5d61688e |
institution | Directory Open Access Journal |
issn | 2214-031X |
language | English |
last_indexed | 2024-04-09T15:20:23Z |
publishDate | 2023-03-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Orthopaedic Translation |
spelling | doaj.art-610da7cd26ff4b958e1c3d0b5d61688e2023-04-29T14:49:49ZengElsevierJournal of Orthopaedic Translation2214-031X2023-03-0139177190MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335–5p signaling pathwayKewen Zhang0Wuxia Qiu1Hui Li2Jun Li3Pai Wang4Zhihao Chen5Xiao Lin6Airong Qian7Lab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering; Key Lab for Space Biosciences and Biotechnology, China; School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, ChinaLab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering; Key Lab for Space Biosciences and Biotechnology, China; School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; School of Chemical Engineering, Sichuan University of Science & Engineering, Zigong, ChinaDepartment of Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, ChinaDepartment of Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, ChinaLab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering; Key Lab for Space Biosciences and Biotechnology, China; School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, ChinaLab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering; Key Lab for Space Biosciences and Biotechnology, China; School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, ChinaLab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering; Key Lab for Space Biosciences and Biotechnology, China; School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Research & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen City, 518063, China; Corresponding authorSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, ChinaLab for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering; Key Lab for Space Biosciences and Biotechnology, China; School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Corresponding authorSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.Background: The decreased osteogenic differentiation ability of mesenchymal stem cells (MSCs) is one of the important reasons for SOP. Inhibition of Wnt signaling in MSCs is closely related to SOP. Microtubule actin crosslinking factor 1 (MACF1) is an important regulator in Wnt/β-catenin signal transduction. However, whether the specific expression of MACF1 in MSC regulates SOP and its mechanism remains unclear. Methods: We established MSC-specific Prrx1 (Prx1) promoter-driven MACF1 conditional knock-in (MACF-KI) mice, naturally aged male mice, and ovariectomized female mice models. Micro-CT, H&E staining, double calcein labeling, and the three-point bending test were used to explore the effects of MACF1 on bone formation and bone microstructure in the SOP mice model. Bioinformatics analysis, ChIP-PCR, qPCR, and ALP staining were used to explore the effects and mechanisms of MACF1 on MSCs’ osteogenic differentiation. Results: Microarray analysis revealed that the expression of MACF1 and positive regulators of the Wnt pathway (such as TCF4, β-catenin, Dvl) was decreased in human MSCs (hMSCs) isolated from aged osteoporotic than non-osteoporotic patients. The ALP activity and osteogenesis marker genes (Alp, Runx2, and Bglap) expression in mouse MSCs was downregulated during aging. Furthermore, Micro-CT analysis of the femur from 2-month-old MSC-specific Prrx1 (Prx1) promoter-driven MACF1 conditional knock-in (MACF-cKI) mice showed no significant trabecular bone changes compared to wild-type littermate controls, whereas 18- and 21-month-old MACF1 c-KI animals displayed increased bone mineral densities (BMD), improved bone microstructure, and increased maximum compression stress. In addition, the ovariectomy (OVX)-induced osteoporosis model of MACF1 c-KI mice had significantly higher trabecular volume and number, and increased bone formation rate than that in control mice. Mechanistically, ChIP-PCR showed that TCF4 could bind to the promoter region of the host gene miR-335–5p. Moreover, MACF1 could regulate the expression of miR-335–5p by TCF4 during the osteogenic differentiation of MSCs. Conclusion: These data indicate that MACF1 positively regulates MSCs osteogenesis and bone formation through the TCF4/miR-335-5p signaling pathway in SOP, suggesting that targeting MACF1 may be a novel therapeutic approach against SOP. The translational potential of this article: MACF1, an important switch in the Wnt signaling pathway, can alleviate SOP through the TCF4/miR-335-5p signaling pathway in mice model. It might act as a therapeutic target for the treatment of SOP to improve bone function.http://www.sciencedirect.com/science/article/pii/S2214031X2300013XMACF1Senile osteoporosisBone formationmiR-335-5pWnt signaling |
spellingShingle | Kewen Zhang Wuxia Qiu Hui Li Jun Li Pai Wang Zhihao Chen Xiao Lin Airong Qian MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335–5p signaling pathway Journal of Orthopaedic Translation MACF1 Senile osteoporosis Bone formation miR-335-5p Wnt signaling |
title | MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335–5p signaling pathway |
title_full | MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335–5p signaling pathway |
title_fullStr | MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335–5p signaling pathway |
title_full_unstemmed | MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335–5p signaling pathway |
title_short | MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335–5p signaling pathway |
title_sort | macf1 overexpression in bmscs alleviates senile osteoporosis in mice through tcf4 mir 335 5p signaling pathway |
topic | MACF1 Senile osteoporosis Bone formation miR-335-5p Wnt signaling |
url | http://www.sciencedirect.com/science/article/pii/S2214031X2300013X |
work_keys_str_mv | AT kewenzhang macf1overexpressioninbmscsalleviatessenileosteoporosisinmicethroughtcf4mir3355psignalingpathway AT wuxiaqiu macf1overexpressioninbmscsalleviatessenileosteoporosisinmicethroughtcf4mir3355psignalingpathway AT huili macf1overexpressioninbmscsalleviatessenileosteoporosisinmicethroughtcf4mir3355psignalingpathway AT junli macf1overexpressioninbmscsalleviatessenileosteoporosisinmicethroughtcf4mir3355psignalingpathway AT paiwang macf1overexpressioninbmscsalleviatessenileosteoporosisinmicethroughtcf4mir3355psignalingpathway AT zhihaochen macf1overexpressioninbmscsalleviatessenileosteoporosisinmicethroughtcf4mir3355psignalingpathway AT xiaolin macf1overexpressioninbmscsalleviatessenileosteoporosisinmicethroughtcf4mir3355psignalingpathway AT airongqian macf1overexpressioninbmscsalleviatessenileosteoporosisinmicethroughtcf4mir3355psignalingpathway |